Symptoms of Anxiety, Depression, and Stress among Families of Critically Ill Patients with COVID-19: A Longitudinal Clinical Trial [0.03%]
COVID-19重症患者家属焦虑、抑郁和压力症状的纵向临床试验研究
Kalli A Sarigiannis,Jonathan J Tringali,James Vu et al.
Kalli A Sarigiannis et al.
Rationale: Families of critically ill patients with coronavirus disease (COVID-19) may be at particularly high risk for anxiety, depression, and post-traumatic stress disorder after hospital discharge. Objectives: To assess symptoms of anxi...
Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity [0.03%]
肺结节病：超越限制和强制 vital 容量的范畴
Ogugua Ndili Obi
Ogugua Ndili Obi
Preventing Continuous Damage in Primary Ciliary Dyskinesia: Is Airway Inflammation a Potential Target? [0.03%]
原发性纤毛运动障碍中防止持续损伤的作用：气道炎症是可能的目标吗？
Dvir Gatt,Felix Ratjen
Dvir Gatt
Coverage Decisions for Positive Airway Pressure Therapy: Intended and Unintended Consequences [0.03%]
正空气道压力治疗的覆盖决定：有意和无意的结果
Kevin I Duan,Lucas M Donovan
Kevin I Duan
Avnee Kumar,Layla Nasr,Anna Barker et al.
Avnee Kumar et al.
The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report [0.03%]
与电子烟使用相关的肺损伤流行病：发病机制、管理和未来方向：美国胸科协会工作坊报告
Meghan E Rebuli,Jason J Rose,Alexandra Noël et al.
Meghan E Rebuli et al.
E-cigarette or vaping product use-associated lung injury (EVALI) is a severe pulmonary illness associated with the use of e-cigarettes or vaping products that was officially identified and named in 2019. This American Thoracic Society works...
Acetazolamide as an Adjunct to Positive Airway Pressure Therapy in the Treatment of Combined Central and Obstructive Sleep Apnea [0.03%]
acetazolamide作为正压通气治疗合并中枢性及阻塞性睡眠呼吸暂停的一种辅助疗法
Steven C Scherping rd,Mark Quigg,Eric M Davis
Steven C Scherping rd
Longitudinal Magnetic Resonance Imaging Detects Onset and Progression of Chronic Rhinosinusitis from Infancy to School Age in Cystic Fibrosis [0.03%]
纵向磁共振成像检测囊性纤维化儿童从婴儿期到学龄期慢性鼻窦炎的发作和进展
Lena Wucherpfennig,Felix Wuennemann,Monika Eichinger et al.
Lena Wucherpfennig et al.
Rationale: Chronic rhinosinusitis (CRS) contributes to morbidity in patients with cystic fibrosis (CF). However, longitudinal data on CRS onset and progression is lacking. Objectives: To longitudinally evaluate CRS in CF from infancy to sch...
Judy M Bradley,Kathryn Ferguson,Andrew Bailey et al.
Judy M Bradley et al.
Rationale: There is a lack of outcome measures with robust clinimetric properties in bronchiectasis. Objectives: To determine the clinimetric properties (reliability over 1 year during clinical stability and responsiveness over the course o...
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial [0.03%]
成人阻塞性睡眠呼吸暂停患者奥昔布宁联合阿托莫西汀治疗的随机双盲对照研究
Atqiya Aishah,Kelly A Loffler,Barbara Toson et al.
Atqiya Aishah et al.
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity in short-term (⩽1 wk) proof-of-concept studies. Objectives: To...
Randomized Controlled Trial
Annals of the American Thoracic Society. 2023 Apr;20(4):584-595. DOI:10.1513/AnnalsATS.202206-492OC 2023